Search results for abx831348

Opicinumab, Abbexa, abx831348

Opicinumab is a monoclonal antibody biosimilar expressed in CHO cells, targeting LINGO1/LRRN6A/LERN1, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Opicinumab is under investigation in clinical trial NCT02641041 (Safety, Tolerability, and Pharmacokinetics of Single and Multiple Doses of BIIB033 in Healthy Japanese Participants).